Product image of Emtricitabina + Tenofovir Generis (Emtricitabine, Tenofovir Disoproxil Fumarate) supplied by GNH India

Emtricitabina + Tenofovir Generis

Active Ingredient:
Emtricitabine, Tenofovir Disoproxil Fumarate
Origin:
EU

Emtricitabina + Tenofovir Generis (Emtricitabine, Tenofovir Disoproxil Fumarate)

Emtricitabine + Tenofovir Generis is a combination medication used for HIV treatment and prevention. This oral medication helps manage HIV infection and reduce the risk of transmission.

Manufacturer / TM Owner

Generis Farmacêutica, S.A.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Emtricitabine + Tenofovir Generis is primarily used in the treatment of HIV-1 infection in adults and adolescents. It is often prescribed as part of a combination therapy to control the virus and improve immune function. This medication is also used for pre-exposure prophylaxis (PrEP) to prevent HIV infection in individuals at high risk.

Side Effects

  • Common effects of Emtricitabine + Tenofovir Generis may include headache, nausea, diarrhea, and fatigue. Some users may experience dizziness or rash. These effects vary and are not experienced by everyone.

Precautions & Warnings

  • Emtricitabine + Tenofovir Generis should be used with caution in individuals with kidney problems or bone density issues. Regular monitoring of kidney function and bone health is recommended. Always follow the advice of a healthcare provider.

Avoid Interactions

  • Emtricitabine + Tenofovir Generis may interact with other medications, including those that affect kidney function or bone health. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions.

Frequently Asked Questions

Emtricitabine + Tenofovir Generis is used to treat HIV-1 infection and for pre-exposure prophylaxis (PrEP) to prevent HIV in high-risk individuals.

Emtricitabine + Tenofovir Generis is taken orally, typically once daily. Follow the instructions provided by your healthcare provider.

Common side effects may include headache, nausea, diarrhea, and fatigue. Some users may experience dizziness or rash.

Emtricitabine + Tenofovir Generis may interact with other medications. Consult your healthcare provider before combining it with other treatments.

Emtricitabine + Tenofovir Generis should be used with caution in individuals with kidney problems or bone density issues. Always follow medical advice.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Emtricitabine, Tenofovir Disoproxil Fumarate

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT